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ABSTRACT. Mutations in the Wilms’ tumor suppressor gene (WT1) 
can lead to syndromic forms of steroid-resistant nephrotic syndrome 
(SRNS) such as Denys-Drash or Frasier syndrome and can cause 
isolated SRNS. A mutation within WT1 is a frequent cause of sporadic 
isolated SRNS in girls. In a worldwide cohort of girls, the rate of 
occurrence was 10.8%. Previous reports have indicated that in Chinese 
girls, the detection rate of WT1 mutations is 16.7% for early onset 
isolated nephrotic syndrome. The detection rate of WT1 mutations in 
Chinese girls with sporadic isolated SRNS is unknown. We examined 
WT1 mutations in 14 Chinese girls with sporadic isolated SRNS using 
polymerase chain reaction and direct sequencing and studied a control 
group of 38 boys with sporadic isolated SRNS. We identified a WT1 
mutation in 1 of 14 (7.1% detection rate) Chinese girls with sporadic 
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isolated SRNS. No mutations occurred in WT1 in the remaining 13 girls 
or the control group. Our investigation supports the necessity of genetic 
examination for mutations in WT1 in girls with sporadic isolated SRNS.
Key words: Steroid-resistant nephrotic syndrome; Mutation; Genetics; 
Wilms’ tumor suppressor gene
INTRODUCTION
Idiopathic nephrotic syndrome (NS) is characterized by proteinuria, hypoalbuminemia, 
hyperlipidemia, and edema. It is the most common of the childhood glomerular diseases (Yu et 
al., 2005). Idiopathic NS is divided into steroid-sensitive NS and steroid-resistant NS (SRNS) 
based on patient response to steroid treatment. Most children with sporadic idiopathic NS re-
spond to steroids and have a favorable long-term prognosis; however, 10-20% of patients do 
not respond and may progress to end-stage renal disease (Ruf et al., 2004a; Weber et al., 2004). 
Previous studies have demonstrated that mutations in the genes encoding podocyte proteins 
such as NPHS2 [Online Mendelian Inheritance in Man (OMIM) 604766] and Wilms’ tumor 
suppressor gene (WT1; OMIM 607102) are responsible for SRNS (Boute et al., 2000; Mucha et 
al., 2006). NPHS2 has been mapped to chromosome 1q25-31, and the encoding podocin causes 
autosomal recessive SRNS (Boute et al., 2000). Mutations in NPHS2 are responsible for 45-
55% of familial SRNS with autosomal recessive inheritance (Boute et al., 2000; Caridi et al., 
2005). NPHS2 mutation is a frequent cause of sporadic SRNS, occurring in 10-28% of children 
with sporadic SRNS (Karle et al., 2002; Ruf et al., 2004a; Weber et al., 2004).
The WT1 gene, located on chromosome 11p13 and consisting of 10 exons, plays a 
crucial role in kidney and genital system development (Call et al., 1990; Haber et al., 1991; 
Bruening et al., 1992). Mutations in WT1 can lead to syndromic forms of SRNS such as 
Denys-Drash syndrome (OMIM 194080) (Pelletier et al., 1991) and Frasier syndrome (OMIM 
136680) (Barbaux et al., 1997) and can cause isolated SRNS (Mucha et al., 2006). Denys-
Drash syndrome is characterized by the triad of infantile SRNS, ambiguous genitalia, and 
Wilms’ tumor (Chernin et al., 2010). Frasier syndrome is characterized by the association of 
SRNS with male pseudohermaphroditism (Chernin et al., 2010). Isolated SRNS herein refers 
to SRNS without accompanying genital abnormalities, Wilms’ tumor, ocular abnormalities, 
audiological abnormalities, or mental retardation. Although WT1 mutations have been found 
in only 3 boys with isolated NS (Takata et al., 2000; Chernin et al., 2010; Yang et al., 2013), 
they are a frequent cause of sporadic isolated SRNS in girls, occurring in 10.8% of girls in 
a worldwide cohort (Mucha et al., 2006). Previous studies have indicated that the screening 
of WT1 exons 8 and 9 in patients with sporadic SRNS is sufficient to detect pathogenic WT1 
mutations (Ruf et al., 2004b; Mucha et al., 2006).
Idiopathic NS is also the most frequent glomerular disease in Chinese children, of 
whom 20% with idiopathic NS show steroid resistance, a percentage similar to that in other 
countries (Yu et al., 2005). A previous study has reported a 16.7% detection rate of WT1 muta-
tions in Chinese girls with early onset isolated NS (Li et al., 2010).
To the best of our knowledge, the detection rate of WT1 mutations in Chinese girls 
with sporadic isolated SRNS remains unknown. Therefore, we examined mutations in exons 
8 and 9 of WT1 in 14 Chinese girls with sporadic isolated SRNS using polymerase chain reac-
tion (PCR) and direct sequencing.
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MATERIAL AND METHODS
Subjects
We enrolled patients (N = 14) based on the following criteria: 1) they were Chinese 
girls with no familial history of renal diseases and not children of consanguineous marriages; 
2) they were older than 3 months and younger than 18 years at disease onset; 3) they were 
diagnosed with SRNS; 4) they did not develop Wilms’ tumor based on renal ultrasound; 5) 
they lacked symmetrical deficits in sensitivity for high-frequency sounds on audiometry; 6) 
they lacked ocular lesions per ophthalmologic assessment; 7) they lacked post-infectious glo-
merulonephritis and systemic diseases per clinical and laboratory examinations; 8) they lacked 
mental retardation; and 9) they had no NPHS2 mutations. The control group comprised boys 
(N = 38) with sporadic isolated SRNS. NS was diagnosed based on 24-h urinary protein ex-
cretion greater than 0.05 g/kg, with serum albumin less than 25 g/L. Steroid resistance was 
defined as the absence of remission after an initial 4 weeks of steroid therapy at a dose of 2 
mg·kg-1·day-1. We also studied, as controls, unrelated adult volunteers (N = 50) with normal 
urinalyses. This study was approved by the ethics committee of Fuzhou Dongfang Hospital 
(China). Informed consent was obtained from patients or their parents.
WT1 mutational analysis
For genetic analysis of WT1, genomic DNA was isolated from peripheral blood. Ex-
ons 8 and 9 of WT1 were amplified using PCR. The primers used in the PCR amplification of 
exons 8 and 9 of WT1 have been described previously (Mucha et al., 2006). Genomic DNA 
(50 ng) was subjected to 36 cycles of PCR amplification in a 25-μL volume consisting of 1 μL 
5 μM sense primer, 1 μL 5 μM antisense primer, 1.5 μL 25 mM MgCl2, 1 μL 2.5 mM deoxy-
ribonucleotide triphosphates, and 0.125 μL 5 U/μL Taq polymerase (Promega Corporation, 
Madison, WI, USA). The PCR products were visualized using 1.5% (w/v) agarose gel elec-
trophoresis. PCR amplicons were directly sequenced using an ABI 3730XL DNA Analyzer 
(Shanghai Invitrogen Biotechnology Co., Shanghai, China). Mutations were confirmed with 
sequencing in both directions and by repeated amplification and sequencing.
Karyotype analysis or Y chromosome identification
Karyotype analysis was performed on 3 patients. For patient 10, for whom karyotype 
analysis was not performed, the sex-determining region Y gene (a specific marker on the Y 
chromosome) was identified via amplification of SRY using PCR and confirmed with agarose 
gel electrophoresis (Harley et al., 2003). The primers used in the sex-determining region Y 
amplification reactions have been described previously (Tu et al., 2008).
RESULTS
Clinical data
All children (N = 52; 14 girls, 38 boys) with sporadic isolated SRNS lacked genital 
6187
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 12 (4): 6184-6191 (2013)
WT1 mutations in sporadic isolated SRNS
abnormalities, Wilms’ tumor, ocular abnormalities, audiological abnormalities, and mental re-
tardation. In the 14 girls with sporadic isolated SRNS, age at onset was 5.7 ± 3.5 years (range, 
1.2-11.6 years; Table 1). Renal biopsy was carried out on 5 female patients and revealed fo-
cal segmental glomerulosclerosis in 3 patients, diffuse mesangial sclerosis in 1 patient, and 
membranous nephropathy in 1 patient (see Table 1). In the control group, renal biopsy was 
carried out on 14 boys, revealing focal segmental glomerulosclerosis in 5 patients, mesangial 
proliferative glomerulonephritis in 4 patients, and minimal change NS in 5 patients.
Patient Age of onset PU (g/24 h) HU Serum albumin Creatinine SUN GFR Renal biopsy Karyotype
 (years)   (g/L) (μM) (mM) (mL·min-1·1.73 m-2)
  1   1.2 1.810 - 19.6   25.0   4.30   111.00 ND ND
  2   1.8 2.780 + 17.7   43.0   5.78 >120.00 ND ND
  3   2.3 1.780 -   8.8 162.0 18.70     53.34 ND ND
  4   2.5 3.024 + 20.7   24.0   3.70     99.12 ND 46, XX
  5   2.8 0.828 + 14.7   30.0   4.35 >120.00 ND ND
  6   2.9 3.090 - 17.0   30.0   3.10 ND ND ND
  7   4.8 1.600 + 16.0   11.3   3.88 >120.00 FSGS ND
  8   6.6 2.317 + 12.0   48.0   5.50 >120.00 ND ND
  9   7.1 3.410 + 20.1 663.0 28.50       5.40 FSGS 46, XX
10   8.1 2.046 + 17.0   66.0   5.60 ND ND   46, XX*
11   8.3 1.700 + 22.3   56.0   6.30 >120.00 MN 46, XX
12   8.7 1.571 + 12.9   34.0   4.30 >120.00 ND ND
13 10.8 2.380 + 18.0 555.0 34.90       9.60 DMS ND
14 11.6 5.420 + 24.0   51.0   5.50   118.80 FSGS ND
PU = proteinuria; HU = hematuria; SUN = serum urea nitrogen; GFR = glomerular filtration rate; ND = not 
determined; FSGS = focal segmental glomerulosclerosis; MN = membranous nephropathy; DMS = diffuse 
mesangial sclerosis. *Y chromosome identification showed no Y chromosome.
Table 1. Clinical data for 14 female children with sporadic isolated steroid-resistant nephrotic syndrome.
Patient 10 initially presented with transient eyelid edema and massive proteinuria at 8.1 
years old; eyelid edema subsided without any treatment. She was hospitalized at 8.5 years with 
severe eyelid edema and persistent proteinuria within the nephrotic range. Physical examina-
tion revealed eyelid edema and normal female external genitalia. Blood pressure was normal, 
and a urine dipstick revealed 3+ albumin. Her 24-h proteinuria was 2.046 g, and serum albumin 
was 17 g/L. Serum cholesterol was 13.55 mM, serum creatinine was 66 μM, and a renal ultra-
sound was normal. She did not respond to a 6-week course of 2 mg·kg-1·day-1 prednisone. A 
renal biopsy was refused by her parents, and she was diagnosed with isolated SRNS.
WT1 mutational analysis
The WT1 mutation, IVS9+5G>A, was identified in patient 10 but not in the 50 normal 
controls. No mutations in WT1 were found in the other 13 girls or in the control group of 38 
boys. Therefore, the detection rate of WT1 mutations in girls with sporadic isolated SRNS was 
7.1% (1/14).
Karyotype analysis
Karyotype analysis, or Y chromosome identification, showed 46 XX karyotypes in 4 
patients (see Table 1).
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DISCUSSION
In this study, we found that a heterozygous mutation (IVS9+5G>A) in WT1 was as-
sociated with the occurrence of sporadic isolated SRNS in 1 of 14 Chinese girls. Our results 
support the necessity for genetic examination for WT1 mutations in Chinese girls with spo-
radic isolated SRNS.
The WT1 variant IVS9+5G>A in patient 10 was absent in the 50 normal controls. Pre-
vious studies have reported that the IVS9+5G>A mutation in WT1 can cause Denys-Drash and 
Frasier syndromes and also lead to isolated SRNS (Mucha et al., 2006; Aucella et al., 2006; 
Löwik et al., 2008; Chernin et al., 2010; Li et al., 2010; Gellermann et al., 2010; Megremis 
et al., 2011). A total of 11 girls had isolated SRNS caused by the IVS9+5G>A WT1 mutation 
(Table 2). Their age at onset ranged from 0.25-8.5 years (average 3.5 years). Patient 10 pre-
sented with SRNS at 8.1 years. She had a normal female phenotype and lacked a Y chromo-
some. No tumor was identified using renal ultrasound, and therefore she was diagnosed with 
isolated SRNS. All of her clinical features were similar to those observed in patients with the 
IVS9+5G>A WT1 mutation (Aucella et al., 2006; Löwik et al., 2008; Chernin et al., 2010). We 
considered IVS9+5G>A to be responsible for the clinical manifestations of patient 10.
Patients Genotype/phenotype Age of onset (years) Renal biopsy ESRD (years after onset) References
4 F/F 2.0 FSGS N (17.0) Megremis et al., 2011
IE F/F 6.0 FSGS Y (4.0) Aucella et al., 2006
F921 F/F 2.3 FSGS Y (5.8) Mucha et al., 2006
F1280 F/F 8.1 FSGS N (8.1) Chernin et al., 2010
A562 F/F 5.7 MCNS N (5.7) Chernin et al., 2010
A2074 F/F 3.1 FSGS N (3.1) Chernin et al., 2010
A2328 F/F 0.9 DMS N (0.9) Chernin et al., 2010
P1 F/F 0.3 FSGS Y (2.7) Li et al., 2010
P4 F/F 1.0 ND Y (0.3) Li et al., 2010
P1 F/F 1.0 FSGS N (15.9) Gellermann et al., 2011
P3 F/F 8.5 FSGS Y (6.0) Löwik et al., 2008
ESRD = end-stage renal disease; F = female; FSGS = focal segmental glomerulosclerosis; MCNS = minimal 
change nephrotic syndrome; DMS = diffuse mesangial sclerosis; ND = not determined; Y = yes; N = no.
Table 2. Clinical data from 11 patients with isolated steroid-resistant nephrotic syndrome (SRNS) caused by 
mutation IVS9+5G>A in WT1.
No significant differences occurred among the detection rates of WT1 mutations in 
girls with sporadic isolated SRNS from various ethnic groups (Table 3). In our study, the 
detection rate of WT1 mutations in girls with sporadic isolated SRNS was 7.1% (1/14). Li et 
al. (2010) have screened for WT1 mutations in 12 Chinese girls with early onset isolated NS 
and identified mutations in 2 of the patients. Therefore, the rate of WT1 mutations in girls 
with early onset isolated NS was 16.7% (Li et al., 2010), a rate higher than that determined 
in our study. However, Li et al. (2010) studied girls with onset age greater than 3 years as the 
control group, with no WT1 mutations detected in these patients. When the results of both the 
12 girls with early onset NS and the 12 girls with onset age more than 3 years were combined, 
the detection rate of WT1 mutants was 8.7% (2/24), a result comparable to the findings of the 
present study. Ruf et al. (2004b) have examined WT1 mutations in 54 girls from central Eu-
rope, Turkey, and India with sporadic isolated SRNS. The authors identified WT1 mutations 
in 4 patients (7.4%). Mucha et al. (2006) screened for WT1 mutations in 74 girls with central 
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European, Turkish, African-American, Hispanic, or Asian backgrounds and with sporadic iso-
lated SRNS. They detected WT1 mutations in 8 patients (10.8%). Aucella et al. (2006) have 
examined WT1 mutations in 30 Italian girls with sporadic isolated SRNS and found WT1 
mutations in 2 female patients (6.7%). Cho et al. (2008) have examined WT1 mutations in 37 
Korean girls with sporadic isolated SRNS and identified a WT1 mutation in 1 patient (2.7%). 
When the results of our study and those of previous studies were combined, the detection rate 
of WT1 mutants in girls with sporadic isolated SRNS was 7.7% (18/233) (Ruf et al., 2004b; 
Aucella et al., 2006; Mucha et al., 2006; Cho et al., 2008; Li et al., 2010).
Ethnic background Number of patients (male:female) Detection rate of WT1 mutations References
Worldwide cohort 111 (57:54) Male: 0% (0/57) Ruf et al., 2004b
  Female: 7.4%* (4/54)
Worldwide cohort 158 (84:74) Male: 0% (0/84) Mucha et al., 2006
  Female: 10.8%* (8/74)
Italian   62 (32:30) Male: 0% (0/32) Aucella et al., 2006
  Female: 6.7%* (2/30)
Korean   67 (30:37) Male: 0% (0/30) Cho et al., 2008
  Female: 2.7%* (1/37)
Chinese   67 (43:24) Male: 0% (0/43) Li et al., 2010
  Female: 8.3%* (2/24†)
Chinese   52 (38:14) Male: 0% (0/38) Present study
  Female: 7.1%* (1/14)
*No significant difference among the detection rates of WT1 mutations in the six groups, as analyzed by the chi-
squared test (χ2 = 2.352, P = 0.807). †Includes 12 female patients with early-onset (within 3 years of age) nephrotic 
syndrome and 12 female patients with an onset age greater than 3 year.
Table 3. Detection rates of WT1 mutations in children with sporadic isolated steroid-resistant nephrotic syndrome.
We were unable to identify WT1 mutations in the phenotypically normal 38 male 
patients used as the control group. Previous large studies have also reported that no phenotypi-
cally normal boys without genitourinary malformations and Wilms’ tumor display mutations 
within WT1 (Ruf et al., 2004b; Aucella et al., 2006; Mucha et al., 2006; Cho et al., 2008; Li et 
al., 2010; Mbarek et al., 2011). Only 3 boys with isolated NS have reportedly displayed WT1 
mutations in studies (Takata et al., 2000; Chernin et al., 2010; Yang et al., 2013). Takata et al. 
(2000) have reported that the cause of nephropathy in a 2-year-old boy lacking genital abnor-
malities and Wilms’ tumor was the R312Q WT1 mutation. He rapidly progressed to chronic 
kidney disease stage 5; his karyotype was 46, XY. Chernin et al. (2010) have reported that 
isolated NS in a 1.5-year-old boy was caused by the R394W WT1 mutation. He rapidly pro-
gressed to renal failure at 1.7 years; his karyotype was 46, XY. We have recently reported that 
isolated NS in a 6.3-year-old boy was caused by the K351E WT1 mutation. He rapidly pro-
gressed to end-stage renal disease; his karyotype was 46, XY (Yang et al., 2013). Our results 
further support that mutational analysis of WT1 is not regularly recommended for boys with 
sporadic isolated SRNS. Recently, we identified an identical de novo heterozygous WT1 muta-
tion, R394W, in a pair of Chinese female monozygotic twins. They presented with incomplete 
Denys-Drash syndrome and isolated SRNS (Yu et al., 2012).
In conclusion, we identified a WT1 mutation in 1 of 14 Chinese girls with sporadic 
isolated SRNS, indicative of a 7.1% detection rate for WT1 mutations in these individuals. Our 
investigation supports the necessity of genetic examination for WT1 mutations in Chinese girls 
with sporadic isolated SRNS.
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